Activation of the Thrombopoietin Receptor by Mutant Calreticulin in CALR-Mutant Myeloproliferative Neoplasms
Results from a recent study indicate that mutant CALR may promote myeloproliferative neoplasm development by activating c-MPL and its downstream pathway.
Blood
In The News
American Journal of Managed Care
In The Literature
American Journal of Hematology European Journal of Haematology